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The impact of a programme to improve quality of care for people with type 2 diabetes on hard 





Aims. We investigated whether a continuous quality improvement programme in primary care for 
people with type 2 diabetes led to better care and outcomes in hard to reach groups. 
Methods. GEDAPs was implemented in Catalonia, Spain between 1993 (n=2239) and 2002 (n=5819). 
Process (e.g. education), intermediate (e.g. HbA1c) and final (e.g. retinopathy) outcomes were 
compared between urban and rural areas, and between younger (≤74 years) and older (≥75 years) 
individuals as examples of harder to reach groups.  
Results. In 1993, people in urban areas had significantly better or similar outcomes to rural areas; by 
2002, most outcomes improved in urban and rural areas. For all outcomes, the improvement in rural 
areas was similar to or better than urban areas. Similarly, for most outcomes, the younger and older 
group improved, with the older group experiencing similar or better improvements than the younger 
group for all indicators, except coronary artery disease. 
Conclusions. A quality improvement programme was associated with equivalent or better outcomes in 
hard to reach groups, regardless of whether they were specifically targeted. The ability to apply one 
programme to all populations could save time and money. 
Keywords. Diabetes Mellitus, Type 2; Quality Improvement; Quality of Health Care; Rural Population. 
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Type 2 diabetes mellitus (T2DM) complications are often avoidable through adequate care, thus there 
has been an increase in programmes to improve the quality of routine care received by people with 
T2DM [1]. Generally, such programmes have been shown to impact positively on patients’ care and 
health [2-4], including the GEDAPS programme (Group of Study of Diabetes in Primary Care) which 
was implemented in primary care in Catalonia, Spain between 1993 and 2002 [5,6]. GEDAPS 
resulted in improvements in process, intermediate and final outcomes when the patient population 
was considered as a whole [5,6]. It is however unclear whether quality improvement programmes, 
including GEDAPS, impact positively on all populations or whether a different approach is required for 
some hard to reach groups. 
We examined whether GEDAPS was associated with improvements in process, intermediate and final 
outcomes for two hard to reach populations. GEDAPS was a continuous quality improvement 
programme with a multifactorial approach, and its main aim was to implement the St Vincent 
recommendations [7]. The programme was shown to improve intermediate and long term outcomes 
for patients with T2DM [5,6], and has been partly adopted by the national health service in Spain [8].  
We consider here two groups that are hard to reach in Spain: those living in rural areas and those 
aged 75 years or older. We chose these groups as ensuring that rural areas were reached was a 
focus of GEDAPS, since these areas are often remote, sparsely populated and have a lower socio-
economic status compared with urban areas. Conversely, there was no focus on older age groups, 
and with the aging population of Catalonia and other countries it is important to understand the best 
way to care for older adults with diabetes. Research into this area is very limited, particularly 
regarding older adults, and while quality improvement programmes in rural areas have resulted in 
improved patient outcomes, these tended to be solely conducted in rural areas, rather than as part of 








GEDAPS is described in detail elsewhere [5,6]. Briefly, GEDAPS was implemented in Catalonia, 
where there is a public health system, 70% of the population live in urban areas, and the prevalence 
of diabetes was approximately 4.7% when the programme began [5]. GEDAPS was based on 
continuous quality improvement methodology and primarily consisted of regular publication of 
guidelines, the provision of workshops and seminars, and of data audit and feedback for process 
outcomes. Workshops to disseminate the GEDAPS guidelines and recommendations and to propose 
local corrective interventions were held in Primary Health Care centres approximately every year, and 
were delivered by region. Typically one general practitioner (GP) and one nurse attended from each 
centre, and they were provided with teaching slides to pass on their gained knowledge to other 
members of their centre. Guidelines and proposals were available to health care professionals 
regardless of whether they attended the workshops. Anonymous data feedback consisted of providing 
workshop attendees with average values of key indicators for their centre, the local area and for 
Catalonia, and then discussing these to provide information to improve services, rather than being 
punitive. Ad hoc activities occurred between sessions, such as the transfer of articles on request. 
Centres volunteered to participate in the programme. The number of participating centres increased 
over time as more centres enrolled and as changes to the health care system meant that new centres 




These analyses used data collected at the beginning (1993) and end (2002) of the study. At each 
time-point, data were collected from paper medical records. Centres were asked to only provide data 
pertaining to the year prior to data collection. Summary information about the centre was collected, as 
well as individual level data for approximately 5% (n=30-50) of randomly selected patients with T2DM 
registered at that centre. Patients were excluded if they had type 1 diabetes, had been diagnosed or 
registered at the practice for less than 6 months, were cared for solely by other professionals or in 
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secondary care, were terminally ill or had an extremely limited quality of life, or had not had any 
contact with the centre in the preceding year. If a patient was excluded then the next patient of the 
same gender was included instead. A different random selection was conducted at each time-point, 
thus a series of cross-sectional studies were conducted. Patients were not required to give written 
informed consent because the study was based on retrospective, anonymous clinical records. The 
study was approved by the Consell Assessor de la Diabetis (Advisory Board on Diabetes) of the 




Process, intermediate and final outcomes were used as outcome variables. These were decided upon 
in advance in agreement with the health care professionals in GEDAPS. Process indicators pertain to 
the organisation. This included the occurrence of 2-4 GP/nurse visits, which was perceived to indicate 
sufficient care without overburdening patients with appointments. At least three educational 
interventions were desirable, where education was delivered by nurses and/or GPs, and the number 
of interventions was defined as the number of different educational topics covered, regardless of the 
number of visits required to cover these topics. Other process indicators were the occurrence of at 
least one measurement of blood pressure, HbA1c, total cholesterol, and weight, of screening for 
funduscopy and microalbuminuria, and of a foot examination. The intermediate patient outcomes 
included were reaching American Diabetes Association 2002 [12] target levels for HbA1c (≤8%; 
64mmol/mol), HDL cholesterol (>1mmol/l), total cholesterol (≤5.2mmol/l), body mass index 
(<30kg/m2), blood pressure (≤140/90mmHg), and smoking status (non-smoker). Final patient 
outcomes were the presence of foot ulcers (registered in the clinical record of the foot examination), 
nephropathy (microalbuminuria diagnosed as >30mg/24-hour in 1993 and albumin/creatinine ratio 
>30 mg/dl in 2002), retinopathy (presence of any lesion diagnosed by an ophthalmologist), coronary 
artery disease (acute myocardial infarction or angor pectoris recorded in primary care or hospital 
records), stroke or transient ischaemic attack (recorded in primary care or hospital records) and 
hospital admission for amputation, hypoglycaemia or glycaemia >500 mg/dl. All outcome variables 
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were binary. Individual demographic characteristics were gender, age and duration of diabetes. 
Urban/rural status of the centre was reported by an individual working at the centre. 
 
Statistical analysis 
Centre and participant characteristics are presented by year. Count and continuous variables are 
presented as n (%) and mean (standard deviation), and were compared between years using chi-
squared tests and t-tests, respectively. In preliminary analyses, age and sex were significantly 
different in 1993 and 2002, therefore results were directly standardised to the age and sex 
distribution, as appropriate, of the 1993 population.  For each outcome, the age and sex standardised 
percentage (standard error) of people attaining it was summarised by urban/rural status separately by 
year, and the age and sex standardised change (95% confidence interval) from 1993 to 2002 was 
estimated separately by urban/rural status; these values were compared using a linear hypothesis 
test. The same analysis was performed for age group (≤74 years, ≥75 years), except that results were 
only sex standardised. Analyses were performed in Stata v13, p-values were two-sided, and p <0.05 
was treated as statistically significant. 
 
Results 
Table 1 shows characteristics of the centres and participants. There was not a significant change in 
the percentage of urban centres between 1993 and 2002 (P=0.41). There were more male (P<0.001) 
and older (P<0.001) participants in 2002 than 1993. The average diabetes duration was also longer in 
2002 (P<0.01), but this was due to the older age of the 2002 cohort (data not shown). 
Table 2 compares urban and rural areas. In 1993, those living in urban areas had significantly better 
outcomes than those in rural areas for GP/nurse visits (P=0.02), educational interventions (P<0.001), 
and having an HbA1c measurement (P<0.05), with no significant differences in the other outcomes. In 
2002, those living in urban, compared with rural, areas had significantly better outcomes for GP/nurse 
visits (P=0.02) and funduscopy (P=0.04). Conversely, those living in rural areas were now more likely 
to have better outcomes for educational interventions (P=0.02) and having an HbA1c measurement 
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(P<0.01), as well as blood pressure measurement (P=0.04), foot examination (P<0.001), 
microalbuminuria screening (P=0.01), total cholesterol target (P=0.02), smoking (P=0.02), coronary 
artery disease (P<0.001), stroke (P<0.001), and hospital admission (P<0.001). For most but not all 
outcomes, both the urban and rural areas improved over time. The change from 1993 to 2002 in the 
rural areas was either similar to or better than that observed in the urban areas for all outcomes. 
Table 3 shows the results by age group. In 1992, younger adults had better outcomes for HbA1c 
measurement (P=0.01), cholesterol measurement (P<0.01), funduscopy (P<0.01), foot ulcers 
(P=0.04), nephropathy (P=0.02), and stroke (P=0.02) than older adults, but worse outcomes for blood 
pressure measurement (P=0.03), body mass index target (P=0.03) and smoking (P=0.04). In 2002, 
other than the number of GP/nurse visits, all of the indicators displayed the same direction of 
difference. HbA1c measurement, cholesterol measurement and foot ulcers were now similar between 
the two age groups. Foot examination (P<0.01), microalbuminuria screening (P<0.001), total 
cholesterol target (P<0.001), body mass index target (P<0.001) and smoking (P<0.001) were 
significantly better in older than younger adults, whereas coronary artery disease (P<0.001) and 
hospital admission (P<0.01) were significantly worse. Again, most but not all outcomes improved over 
time in both groups. The change from 1993 to 2002 in the older age group was either similar to or 
better than that observed in the younger age group for all indicators except coronary artery disease. 
 
Discussion 
Our results suggest that a continuous quality improvement programme aimed at improving the care of 
patients with T2DM in primary care was associated with equivalent or better outcomes in hard to 
reach groups, specifically those living in rural areas and adults aged 75 years or older. 
At the start of the study, there were few differences between urban and rural areas with urban areas 
having better outcomes only in terms of three process indicators. By the end of the study, this picture 
had changed somewhat with rural areas having better outcomes for many of the process, 
intermediate and final indicators. Furthermore, the improvements over time tended to be greater in 
rural areas. Since the absolute values in the rural areas were then higher than the urban ones, this 
suggests that there was not a ceiling effect in urban areas and so they had the capacity for further 
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improvement. A possible explanation for the equivalent or greater improvement in rural areas is that 
GEDAPS specifically targeted them for centre recruitment to ensure that they were well represented. 
This targeted recruitment was successful with approximately 40% of the included centres from rural 
areas. Moreover, some aspects of the programme may have made it particularly amenable to rural 
areas. For example, workshops were delivered in all participating regions, and attendees were 
encouraged to disseminate their gained knowledge to other members of their centre. This could have 
resulted in greater knowledge transference to practitioners in rural areas than would have been 
achieved if workshops had only been delivered in urban areas, which would have limited attendance. 
This approach could be easily generalised to other rural areas outside of Catalonia. Another possible 
explanation is that when the programme started the professionals in rural areas could not easily 
access recommendations for diabetes care, so GEDAPS tried to correct this by ensuring that 
recommendations were widely disseminated within rural areas. There was higher attendance at 
workshops held in rural locations supporting this idea. This situation may now be less relevant due to 
widespread internet use in most areas. Other studies have shown previously that quality improvement 
programmes in rural areas can result in improved patient outcomes [9-11]. However, these 
programmes were generally conducted only in rural areas, and the strength of GEDAPS is that it was 
conducted in both rural and urban areas. This is an important distinction because using only one 
programme for both types of area will result in savings in terms of cost and time through economies of 
scale. 
At the start of the study, younger adults had better outcomes for several process and final indicators 
than older adults, whereas older adults had better outcomes for some of the intermediate outcomes. 
By the end of the study, younger adults only had better outcomes than older adults for coronary artery 
disease and hospital admission. Improvements over time in the older age group were similar to or 
better than those in the younger age group for all but one of the indicators. The continued worse 
outcomes for older adults in terms of coronary artery disease and hospital admissions compared with 
younger adults is unsurprising given the high association between these conditions and older age 
[13,14]. More than half of older adults met each of the intermediate targets that are risk factors for 
these conditions suggesting that preventative measures are being put into place. GEDAPS did not 
specifically target care quality in older adults. For many of the indicators, similar improvements were 
seen for both the younger and older adults suggesting that care improvements were made for all 
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patients. This is encouraging as it suggests that the importance of improving care for all patients, and 
not only those who may be easier to treat, was understood and implemented. Research in this area is 
very limited and, to our knowledge, this is the first study to investigate whether a quality improvement 
programme is successful in older adults. This issue is becoming ever more important with the aging 
population of most countries and the increased propensity towards long term conditions of older 
adults [15], and suggests that it may be appropriate to approach the care of older adults with T2DM in 
a similar way to that for younger adults.  
Overall, some process indicators were very high in 2002, but further improvements could be 
achieved. The percentage of people with more than three educational interventions and weight 
measurements was approximately 35%. While these could be improved upon, it may be that these 
process indicators were set too high to reflect clinical practice, even though they were defined with 
health care professionals. Patients may need less than three educational interventions depending on 
which topics are relevant to them. Moreover, they may not attend their health centre three or more 
times per year, and most guidelines recommend measuring weight as part of a routine health visit and 
in line with clinical judgement so it would usually be inappropriate to call people in solely to measure 
their weight. The percentage of people who had funduscopy was also below 50% and actually 
decreased over time. Funduscopy is performed by an ophthalmologist and there are many barriers to 
it taking place, such as lack of referral by the GP, and patient’s ability to attend an appointment with 
the ophthalmologist either due to time limitations or inability to travel. It is notable that funduscopy 
rates were higher in urban than rural areas, which is probably because ophthalmologists tend to be 
based in urban areas.  
The intermediate target with the lowest adherence was total cholesterol. There was a large increase 
in the percentage of patients reaching cholesterol targets from approximately 25% in 1993 to 45% in 
2002, which may be largely due to the increased use of statins during this period [16]. However, our 
findings suggest that further improvements are still required, which can be achieved through a 
combination of improved dietary intake, more exercise and statin use [17]. Retinopathy and coronary 
artery disease were the most common final outcomes and were experienced by approximately 12% of 
the study population in 2002. This may be a consequence of the noted low rates of funduscopy 
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attendance and attaining cholesterol targets, further suggesting that these are areas on which future 
interventions should focus.  
The primary limitation of this study is that there was no control group. This was because the 
programme was not initially designed to be part of a study, but was instead a clinical endeavour. This 
limits the extent to which it is possible to draw conclusions that observed changes were a 
consequence of the programme, rather than external influences. Indeed, while the programme is 
likely to have contributed towards these changes, they probably also reflect general trends towards 
better care to some extent, since similar improvements over this time period were noted in other 
countries [3,18,19]. Only a selection of patients was included from each centre, because data were 
collected by paper record, but this should have a minimal effect because patients were selected 
randomly, and the analysis adjusted for demographic factors. Participation in the study was voluntary, 
and so included centres may have been more motivated. However, only one health care professional 
per centre was responsible for the study, thus it does not necessarily follow that the whole centre was 
motivated and the impact of this limitation is likely to be small. Finally, the study data are now 
relatively old (1993-2002), however these results remain relevant because the aspects of diabetes 
care considered, such as regular screening and measurement, are still advocated. The study has 
many strengths, including the multifactorial, pragmatic approach of the programme, the adoption of 
the programme into practice ensuring that findings are clinically relevant, the availability of long term 
outcomes, and the large sample. 
In conclusion, we have demonstrated that a programme aimed at improving the quality of care of 
patients with T2DM in primary care was associated with improved outcomes in hard to reach 
populations, namely those living in rural areas and adults aged 75 years or older, regardless of 
whether these hard to reach populations were specifically targeted. Further research is required to 
determine whether this is the case for other quality improvement programmes as the ability to apply 
one programme to all populations has implications in terms of time and cost savings. 
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Table 1. Characteristics of participating centres and their patients. 
 1993 2002 P-value 
Centre characteristics    
  Number of participating centres 55 (100.0) 92 (100.0)  
  Urban centres 36 (65.5) 54 (58.7) 0.410 
Participant characteristics    
  Number of participants 2239 (100.0) 5819 (100.0)  
  Female 1268 (56.6) 3017 (51.8) <0.001 
  Age, years 65.2 [10.2] 67.3 [10.9] <0.001 
  Diabetes duration, years 7.5 [7.1] 8.0 [7.0] 0.004 
Data are n (%) or mean [standard deviation]. 
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Table 2. Age and sex standardised percentages for key patient-level indicators by year and urban/rural status. 









P-value  Urban Rural P-value 
Process outcomes            
2-4 GP/nurse visits 16.51 (0.95) 12.94 (1.23) 0.022  28.59 (0.79) 25.74 (0.94) 0.020  12.08 (9.65, 14.51) 12.80 (9.77, 15.83) 0.716 
≥3 educational interventions 28.14 (1.15) 19.94 (1.47) <0.001  34.46 (0.83) 37.62 (1.05) 0.018  6.32 (3.53, 9.11) 17.68 (14.15, 21.22) <0.001 
≥1 BP measurement 94.29 (0.59) 94.75 (0.82) 0.651  91.43 (0.49) 92.92 (0.56) 0.040  -2.87 (-4.37, -1.37) -1.80 (-3.74, 0.14) 0.393 
≥1 HbA1c measurement 69.59 (1.19) 65.37 (1.75) 0.045  85.61 (0.61)  88.58 (0.69) 0.001  16.02 (13.41, 18.63) 23.22 (19.54, 26.89) 0.002 
≥1 cholesterol measurement 74.70 (1.12) 78.16 (1.51) 0.066  85.94 (0.61) 87.50 (0.72) 0.097  11.24 (8.75, 13.73) 9.35 (6.06, 12.63) 0.368 
≥3 weight measurements 40.36 (1.26) 41.86 (1.80) 0.496  35.51 (0.84) 33.39 (1.02) 0.110  -4.86 (-7.83, -1.89) -8.47 (-12.53, -4.41) 0.160 
Funduscopy 53.17 (1.31) 50.07 (1.86) 0.173  48.32 (0.88) 45.47 (1.09) 0.041  -4.85 (-7.94, -1.76) -4.61 (-8.84, -0.38) 0.927 
Foot examination 49.58 (1.29) 47.62 (1.83) 0.382  52.52 (0.87) 61.98 (1.05) <0.001  2.94 (-0.10, 5.99) 14.35 (10.22, 18.49) <0.001 
Microalbuminuria screening 34.98 (1.23) 31.68 (1.71) 0.116  70.96 (0.79) 74.08 (0.95) 0.012  35.98 (33.11, 38.86) 42.41 (38.58, 46.24) 0.009 
            
Intermediate targets            
HbA1c ≤8 % (64 mmol/mol) 61.99 (1.63) 64.49 (2.88) 0.451  78.48 (0.78) 77.42 (0.98) 0.399  16.49 (12.94, 20.04) 12.93 (6.97, 18.90) 0.315 
HDL cholesterol >1 mmol/l 73.75 (1.88) 77.29 (2.68) 0.279  80.15 (0.77) 81.53 (0.93) 0.252  6.40 (2.42, 10.37) 4.24 (-1.31, 9.80) 0.537 
Total cholesterol ≤5.2 mmol/l 25.67 (1.27) 25.79 (1.81) 0.955  43.71 (0.92) 47.23 (1.14) 0.017  18.04 (14.96, 21.12) 21.44 (17.24, 25.63) 0.201 
Body mass index <30 kg/m2 63.07 (1.39) 64.42 (1.94) 0.573  53.76 (0.97) 56.26 (1.17) 0.099  -9.31 (-12.64, -5.98) -8.15 (-12.60, -3.71) 0.683 
BP ≤140/90 mmHg 49.02 (1.30) 46.63 (1.82) 0.285  64.87 (0.86) 63.29 (1.08) 0.251  15.85 (12.79, 18.91) 16.66 (12.51, 20.80) 0.759 
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Non-smoker 85.74 (0.86) 87.77 (1.19) 0.166  83.94 (0.62) 86.08 (0.69) 0.021  -1.80 (-3.88, 0.28) -1.69 (-4.38, 1.00) 0.951 
            
Final outcomes            
Ulcers 7.59 (0.68) 7.62 (0.96) 0.984  1.99 (0.24) 2.18 (0.29) 0.620  -5.60 (-7.01, -4.18) -5.44 (-7.40, -3.48) 0.896 
Nephropathy 7.66 (0.69) 6.56 (0.91) 0.330  10.35 (0.53) 11.50 (0.68) 0.180  2.68 (0.99, 4.38) 4.94 (2.72, 7.16) 0.113 
Retinopathy 19.32 (1.02) 17.64 (1.38) 0.329  10.03 (0.52) 9.28 (0.63) 0.358  -9.29 (-11.53, -7.05) -8.36 (-11.34, -5.39) 0.627 
Coronary artery disease 13.78 (0.93) 10.88 (1.17) 0.052  12.74 (0.59) 9.29 (0.60) <0.001  -1.03 (-3.18, 1.12) -1.59 (-4.16, 0.98) 0.745 
Stroke 7.63 (0.73) 5.62 (0.87) 0.077  6.10 (0.43) 4.00 (0.40) <0.001  -1.53 (-3.19, 0.13) -1.62 (-3.50, 0.26) 0.944 
Hospital admissiona 3.60 (0.50) 4.12 (0.73) 0.557  7.28 (0.47) 5.03 (0.47) <0.001  3.68 (2.34, 5.03) 0.91 (-0.79, 2.61) 0.012 
Abbreviations: BP, Blood Pressure; CI, Confidence Interval; SE, Standard Error. 
a For amputation, hypoglycaemia or glycaemia > 500 mg/dl  
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Table 3. Sex standardised percentages for key patient-level indicators by year and age group. 
 Percentage (SE) in 1993  Percentage (SE) in 2002  Difference (95% CI) from 1993 to 2002 
 ≤74 years ≥75 years P-value  ≤74 years ≥75 years P-value  ≤74 years ≥75 years P-value 
Process outcomes            
2-4 GP/nurse visits 14.79 (0.82) 16.63 (1.99) 0.392  27.75 (0.70) 27.03 (1.11) 0.585  12.96 (10.85, 15.07) 10.40 (5.94, 14.87) 0.310 
≥3 educational visits 26.23 (1.02) 22.76 (2.26) 0.161  35.92 (0.75) 34.28 (1.19) 0.243  9.69 (7.21, 12.17) 11.52 (6.52, 16.52) 0.520 
≥1 BP measurement 94.14 (0.54) 96.54 (0.97) 0.030  91.66 (0.42) 94.73 (0.56) <0.001  -2.48 (-3.82, -1.14) -1.81 (-4.00, 0.39) 0.609 
≥1 HbA1c measurement 69.32 (1.07) 62.23 (2.59) 0.012  86.94 (0.52) 86.06 (0.87) 0.383  17.63 (15.30, 19.96) 23.83 (18.47, 29.18) 0.038 
≥1 cholesterol measurement 77.21 (0.97) 69.94 (2.43) 0.006  86.69 (0.53) 86.28 (0.86) 0.684  9.48 (7.31, 11.65) 16.34 (11.29, 21.39) 0.015 
≥3 weight measurements 40.15 (1.13) 44.14 (2.65) 0.167  34.27 (0.74) 36.26 (1.21) 0.160  -5.88 (-8.53, -3.23) -7.88 (-13.58, -2.17) 0.534 
Funduscopy 53.82 (1.17) 44.49 (2.75) 0.002  47.97 (0.78) 43.86 (1.26) 0.006  -5.85 (-8.61, -3.08) -0.63 (-6.55, 5.30) 0.118 
Foot examination 48.62 (1.16) 50.66 (2.66) 0.482  55.49 (0.77) 60.17 (1.23) 0.001  6.87 (4.14, 9.60) 9.50 (3.76, 15.25) 0.416 
Microalbuminuria screening 34.37 (1.10) 30.87 (2.45) 0.192  71.18 (0.70) 77.11 (1.05) <0.001  36.81 (34.24, 39.37) 46.24 (41.01, 51.46) 0.002 
            
Intermediate targets            
HbA1c ≤8 % (64 mmol/mol) 62.05 (1.55) 61.75 (3.80) 0.943  77.85 (0.70) 80.14 (1.09) 0.076  15.81 (12.48, 19.14) 18.39 (10.64, 26.15) 0.549 
HDL cholesterol >1 mmol/l 74.09 (1.67) 77.36 (4.50) 0.496  80.58 (0.68) 82.26 (1.08) 0.188  6.48 (2.94, 10.02) 4.89 (-4.18, 13.97) 0.749 
Total cholesterol ≤5.2 mmol/l 25.72 (1.13) 24.49 (2.75) 0.680  44.06 (0.82) 50.39 (1.33) <0.001  18.34 (15.59, 21.08) 25.90 (19.90, 31.89) 0.025 
Body mass index <30 kg/m2 61.78 (1.23) 68.95 (3.07) 0.030  52.50 (0.86) 65.99 (1.30) <0.001  -9.29 (-12.23, -6.34) -2.96 (-9.49, 3.57) 0.084 
BP ≤140/90 mmHg 49.23 (1.18) 43.60 (2.66) 0.053  64.86 (0.78) 60.58 (1.25) 0.004  15.63 (12.86, 18.41) 16.98 (11.22, 22.74) 0.680 
Non-smoker 86.15 (0.76) 90.06 (1.78) 0.043  83.29 (0.55) 93.17 (0.65) <0.001  -2.86 (-4.70, -1.02) 3.12 (-0.59, 6.83) 0.005 
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Final outcomes            
Foot ulcers 6.94 (0.59) 10.60 (1.63) 0.035  2.04 (0.22) 2.83 (0.42) 0.092  -4.90 (-6.12, -3.67) -7.77 (-11.07, -4.47) 0.110 
Nephropathy 6.47 (0.57) 10.42 (1.58) 0.019  10.87 (0.47) 10.39 (0.76) 0.597  4.39 (2.95, 5.84) -0.02 (-3.46, 3.41) 0.020 
Retinopathy 19.32 (0.92) 16.63 (1.99) 0.219  9.51 (0.46) 10.67 (0.77) 0.199  -9.81 (-11.81, -7.80) -5.96 (-10.14, -1.78) 0.104 
Coronary artery disease 12.58 (0.79) 14.36 (1.99) 0.406  10.44 (0.49) 16.99 (0.97) <0.001  -2.15 (-3.97, -0.32) 2.62 (-1.71, 6.96) 0.047 
Stroke 6.12 (0.58) 10.42 (1.75) 0.020  4.43 (0.33) 9.17 (0.75) <0.001  -1.70 (-3.01, -0.38) -1.25 (-4.99, 2.49) 0.825 
Hospital admissiona 3.76 (0.45) 4.00 (1.08) 0.835  6.07 (0.39) 8.58 (0.74) 0.003  2.31 (1.14, 3.48) 4.58 (2.02, 7.13) 0.114 
Abbreviations: BP, Blood Pressure; CI, Confidence Interval; SE, Standard Error. 
a For amputation, hypoglycaemia or glycaemia > 500 mg/dl 
